1-2 of 2
Su-Yu Zhu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Clinical Trials & Observations
Shu-Nan Qi, Yong Yang, Yu-Qin Song, Ying Wang, Xia He, Chen Hu, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Xue-Ying Qiao, Hua Wang, Gao-Feng Li, Hui-Qiang Huang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Li-Ming Xu, Zhi-Yong Yuan, Hang Su, Jun Zhu, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3141–3153.
https://doi.org/10.1182/bloodadvances.2020001852
Published: 2020
Includes: Supplemental data
Journal Articles

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Clinical Trials & Observations
Tao Wu, Yong Yang, Su-Yu Zhu, Mei Shi, Hang Su, Ying Wang, Xia He, Li-Ming Xu, Zhi-Yong Yuan, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Sheng-Min Lan, Jun-Xin Wu, Chen Hu, Shu-Nan Qi, Bo Chen, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2369–2377.
https://doi.org/10.1182/bloodadvances.2018021311
Published: 2018
Includes: Supplemental data